Kira Pharmaceuticals
Pioneering a World Free From Complement Disease
20 employees · est. 2017 · Cambridge, United States
Tessa Therapeutics Ltd
A clinical-stage biotech company developing autologous and allogeneic cell therapies for the treatment of cancer.
47 employees · est. 2001 · Singapore, Singapore
Tessa Therapeutics Ltd is the older company (2017 vs 2001).
Side-by-Side Comparison
| Metric | Kira Pharmaceuticals | Tessa Therapeutics Ltd |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2001 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Singapore, Singapore |
| Employees | ||
| Employees | 20 | 47 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Acquired | Grant |
| Total Funding | ||
| Total Funding | $99.50M | $256.10M |
| Funding Rounds | ||
| Funding Rounds | 5 | 5 |
| Services | ||
| Services | Development of novel complement therapeutics, Clinical research and trials, LOGIC platform-driven drug development, Pipeline management for complement diseases | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with complement-mediated diseases, Healthcare providers, Clinical research institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Pharmaceuticals, Immunology, Oncology, Complement Disease, Clinical-stage, LOGIC Platform, Drug Development, Protein Engineering, Complement Cascade, Therapy, Cambridge, Massachusetts, Suzhou, Shanghai | Biotech Company, Cell Therapies, Cancer Treatment, Clinical-stage, Autologous Cell Therapy, Allogeneic Cell Therapy, CD30-CAR-T Therapy, Hodgkin Lymphoma, RMAT Designation, PRIME Scheme, Off-the-shelf Cell Therapy, EBVSTs, Epstein Barr Virus, Commercial Cell Therapy Manufacturing, Singapore Headquarters |
| Website | ||
| Website | kirapharma.com | tessacell.com |
About Kira Pharmaceuticals
Kira Pharmaceuticals, founded in 2017, stands at the forefront of the biotech industry with its mission to pioneer a world free from complement disease. Leveraging its innovative LOGIC platform, this clinical-stage company has established a robust pipeline of nine novel complement assets, addressing...
About Tessa Therapeutics Ltd
Tessa Therapeutics Ltd is a clinical-stage biotechnology company based in Singapore, focusing on developing autologous and allogeneic cell therapies for the treatment of cancer. The company's autologous CD30-CAR-T therapy TT11 is currently in Phase 2 and 1b clinical trials as a potential treatment f...
We will tell you when either one moves
BounceWatch watches Kira Pharmaceuticals and Tessa Therapeutics Ltd for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Kira Pharmaceuticals and Tessa Therapeutics Ltd — by email.
Frequently Asked Questions
Compare Kira Pharmaceuticals with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Kira Pharmaceuticals on 12 Sep 2024, and Tessa Therapeutics Ltd on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.